Seroconversion rate after vaccination against COVID-19 in patients with cancer—a systematic review
Corti, C., Antonarelli, G., Scotté, F., Spano, J.P., Barrière, J., Michot, J.M., André, F., Curigliano, G.
Published in Annals of oncology (01.02.2022)
Published in Annals of oncology (01.02.2022)
Get full text
Journal Article
Therapeutic cancer vaccines revamping: technology advancements and pitfalls
Antonarelli, G., Corti, C., Tarantino, P., Ascione, L., Cortes, J., Romero, P., Mittendorf, E.A., Disis, M.L., Curigliano, G.
Published in Annals of oncology (01.12.2021)
Published in Annals of oncology (01.12.2021)
Get full text
Journal Article
Management of patients with HER2-positive metastatic breast cancer after trastuzumab deruxtecan failure
Antonarelli, G., Corti, C., Tarantino, P., Salimbeni, B.T., Zagami, P., Marra, A., Trapani, D., Tolaney, S., Cortes, J., Curigliano, G.
Published in ESMO open (01.08.2023)
Published in ESMO open (01.08.2023)
Get full text
Journal Article
42P Comparative real-world analysis of pembrolizumab plus chemo vs platinum-doublet alone in metastatic non-squamous NSCLC with PD-L1 low
Attili, I., Valenza, C., Santoro, C., Antonarelli, G., Trillo Aliaga, P., Del Signore, E., Catania, C., Spitaleri, G., Passaro, A., de Marinis, F.
Published in Annals of oncology (01.04.2022)
Published in Annals of oncology (01.04.2022)
Get full text
Journal Article
165P Correlation between trophoblast cell-surface antigen-2 (Trop-2) expression and pathological complete response (pCR) in HER2-positive early breast cancer (EBC): A sub analysis of PHERGain trial
Gion Cortes, M., Garcia Mosquera, J.J., Pérez-García, J.M., Peg Cámara, V., Guerrero, J.A., López-Montero, L., Mancino, M., Rodríguez Morató, J., Antonarelli, G., Fernández-Murga, L., Serrano García, L., Puglia, V., Llombart Cussac, A., Cortés, J.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
1583P COVID-19 related risk in patients enrolled in early-phase clinical trials
D'Amico, P., Trillo, P., Morganti, S., Corti, C., Vivanet, G., Crimini, E., Ascione, L., Tarantino, P., Antonarelli, G., Locatelli, M., Esposito, A., Belli, C., Curigliano, G.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article
79P Immune-related adverse events are correlated with significantly improved outcome in a phase I trial population exposed to combination immunotherapy
Mazzarella, L., Giugliano, F., Crimini, E., Uliano, J., Corti, C., D'Amico, P., Trillo Aliaga, P., Valenza, C., Repetto, M., Nicolo, E., Antonarelli, G., Ascione, L., Vivanet, G., Berton Giachetti, P.P.M., Belli, C., Criscitiello, C., Esposito, A., Locatelli, M.A., Minchella, I., Curigliano, G.
Published in Annals of oncology (01.12.2021)
Published in Annals of oncology (01.12.2021)
Get full text
Journal Article
83P The Immune-related adverse event (IRAE) Likelihood Score (ILS) identifies “pure” IRAEs strongly associated with outcome in a phase I-II trial population
Mazzarella, L., Nicolo, E., Esposito, A., Crimini, E., Tini, G., Uliano, J., Corti, C., Trillo Aliaga, P.M., Valenza, C., Repetto, M., Antonarelli, G., Minchella, I., Belli, C., Locatelli, M.A., Criscitiello, C., Curigliano, G.
Published in Immuno-oncology technology (01.12.2022)
Published in Immuno-oncology technology (01.12.2022)
Get full text
Journal Article
S912 LOCAL INTERFERON‐ALPHA DELIVERY INTO THE MYELOMA MICROENVIRONMENT BY GENE‐ENGINEERED AUTOLOGOUS STEM CELL TRANSPLANTATION
Antonarelli, G., Mucci, A., Escobar, G., Desantis, G., Vittoria, F. M., Capotondo, A., Naldini, L., Ciceri, F., Gentner, B.
Published in HemaSphere (01.06.2019)
Published in HemaSphere (01.06.2019)
Get full text
Journal Article